Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05144633 · ClinicalTrials.gov registry record
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
A clinical trial of Acute Respiratory Failure, sponsored by University of Louisville.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05144633: Recruiting study of Acute Respiratory Failure, sponsored by University of Louisville.
NCT05144633 is a study of Acute Respiratory Failure that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 100 participants, below the 1,474-participant average among 13 other Acute Respiratory Failure trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05144633, a study of Acute Respiratory Failure, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study that will be enrolling University of Louisville patients who present to the Emergency Department in Acute Respiratory Failure. This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assists with acute respiratory failure diagnosis.
Conditions Studied
Interventions
- DEVICE Auscultation
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-09-09 |
| Est. Completion | 2025-04-30 |
What NCT05144633 shows while recruiting
NCT05144633 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,474-participant average among 13 other Acute Respiratory Failure trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Acute Respiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which Auscultation is the first listed.
NCT05144633 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05144633 about?
NCT05144633 is a clinical study titled "Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)". This is an observational study that will be enrolling University of Louisville patients who present to the Emergency Department in Acute Respiratory Failure. This study will be to determine if the addition of Eko AI-assisted lung auscultation examination to a standard of care Pulmonary POCUS + assis...
What is the current status of trial NCT05144633?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-09-09. Estimated completion is 2025-04-30.
What conditions does trial NCT05144633 study?
This clinical trial studies the following conditions: Acute Respiratory Failure.
What interventions are being tested in trial NCT05144633?
The interventions under investigation include: Auscultation (DEVICE).
Who is sponsoring clinical trial NCT05144633?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05144633 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05144633's enrollment target sits among peer trials
100 10th of 13 higher than 4 of 13 other Acute Respiratory Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Simulation Trial of Telemedical Support for Paramedics
RECRUITING · NA
-
Investigating Dyadic Expectations About ARF Survivorship (IDEAS)
RECRUITING
-
Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adults
RECRUITING
-
Virtual Reality in ICU - PARTNER
RECRUITING
-
The Maximizing Extubation Outcomes Through Educational and Organizational Research (METEOR) Trial
ACTIVE NOT RECRUITING · NA
-
Treatment of Critical Illness Polyneuromyopathy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI